Effect of ramipril on left ventricular mass in normotensive hemodialysis patients

American Journal of Kidney Diseases

Volumn 47, Issue 3, 2006, Pages 478-484

  Yu, Wen Chung ^b   Lin, Yao Ping ^b   Lin, I Feng ^b   Chuang, Shao Yuan ^b   Chen, Chen Huan ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NONE

Author keywords

Arterial stiffness; Left ventricular function; Left ventricular mass; Ramipril; Renal failure

Indexed keywords

PLACEBO; RAMIPRIL;

ADULT; ARTICLE; CARDIOVASCULAR FUNCTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MALE; RANDOMIZED CONTROLLED TRIAL; TONOMETRY;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DOUBLE-BLIND METHOD; FEMALE; HEART VENTRICLES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; RAMIPRIL; RENAL DIALYSIS;

EID: 32844469027     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cap.2005.11.044     Document Type: Article

References (42)

1. R.N. Foley, P.S. Parfrey, M.J. Sarnak Clinical epidemiology of cardiovascular disease in chronic renal disease Am J Kidney Dis 32 suppl 3 1998 S112 S119
2. P.S. Parfrey, R.N. Foley The clinical epidemiology of cardiac disease in chronic renal failure J Am Soc Nephrol 10 1999 1606 1615
3. G.M. London, A.P. Guerin, S.J. Marchais Hemodynamic overload in end-stage renal disease patients Semin Dial 12 1999 77 83
4. G.M. London, S.J. Marchais, A.P. Guerin, F. Metivier, H. Adda Arterial structure and function in end-stage renal disease Nephrol Dial Transplant 17 2002 1713 1724
5. G.M. London, A.P. Guerin, S.J. Marchais Cardiac and arterial interactions in end-stage renal disease Kidney Int 50 1996 600 608
6. J. Blacher, A.P. Guerin, B. Pannier, S.J. Marchais, M.E. Safar, G.M. London Impact of aortic stiffness on survival in end-stage renal disease Circulation 99 1999 2434 2439
7. J. Blacher, B. Pannier, A.P. Guerin, S.J. Marchais, M.E. Safar, G.M. London Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease Hypertension 32 1998 570 574
8. G.M. London, J. Blacher, B. Pannier, A.P. Guerin, S.J. Marchais, M.E. Safar Arterial wave reflections and survival in end-stage renal failure Hypertension 38 2001 434 438
9. A. Kato, T. Takita, Y. Maruyama, H. Kumagai, A. Hishida Impact of carotid atherosclerosis on long-term mortality in chronic hemodialysis patients Kidney Int 64 2003 1472 1479
10. J.S. Silberberg, P.E. Barre, S.S. Prichard, A.D. Sniderman Impact of left ventricular hypertrophy on survival in end-stage renal disease Kidney Int 36 1989 286 290
11. Y.P. Lin, C.H. Chen, W.C. Yu, T.L. Hsu, P.Y. Ding, W.C. Yang Left ventricular mass and hemodynamic overload in normotensive hemodialysis patients Kidney Int 62 2002 1828 1838
12. M.A. Pfeffer, E. Braunwald, L.A. Moye Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction Results of the Survival and Ventricular Enlargement Trial N Engl J Med 327 1992 669 677
13. The SOLVD Investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure N Engl J Med 325 1991 293 302
14. GISSI-3 Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction Lancet 343 1994 1115 1122
15. L. Hansson, L.H. Lindholm, L. Niskanen Effect of angiotensin-converting- enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension The Captopril Prevention Project (CAPPP) randomised trial Lancet 353 1999 611 616
16. S. Yusuf, P. Sleight, J. Pogue, J. Bosch, R. Davies, G. Dagenais Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients N Engl J Med 342 2000 145 153
17. J.F. Mann, H.C. Gerstein, J. Pogue, J. Bosch, S. Yusuf Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril The HOPE randomized trial Ann Intern Med 134 2001 629 636
18. G.M. London, B. Pannier, A.P. Guerin, S.J. Marchais, M.E. Safar, J.-L. Cuche Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease Comparative effects of ACE inhibition and calcium channel blockade Circulation 90 1994 2786 2796
19. R.B. Devereux, E.M. Lutas, P.N. Casale Standardization of M-mode echocardiographic left ventricular anatomic measurements J Am Coll Cardiol 4 1984 1222 1230
20. Y.P. Lin, W.C. Yu, T.L. Hsu, P.Y. Ding, W.C. Yang, C.H. Chen The extracellular fluid-to-intracellular fluid volume ratio is associated with large-artery structure and function in hemodialysis patients Am J Kidney Dis 42 2003 990 999
21. R. Salonen, A. Haapanen, J.T. Salonen Measurement of intima-media thickness of common carotid arteries with high-resolution B-mode ultrasonography Inter- and intra-observer variability Ultrasound Med Biol 17 1991 225 230
22. S.P. Schulman, E.G. Lakatta, J.L. Fleg, L. Lakatta, L.C. Becker, G. Gerstenblith Age-related decline in left ventricular filling at rest and exercise Am J Physiol Heart Circ Physiol 263 1992 H1932 H1938
23. M. McIntyre, R.J. MacFadyen, P.A. Meredith, R. Brouard, J.L. Reid Dose-ranging study of the angiotensin II receptor antagonist irbesartan (SR 47436/BMS-186295) on blood pressure and neurohormonal effects in salt-deplete men J Cardiovasc Pharmacol 28 1996 101 106
24. G. London, A. Guerin, B. Pannier, S. Marchais, A. Benetos, M. Safar Increased systolic pressure in chronic uremia Role of arterial wave reflections Hypertension 20 1992 10 19
25. C.H. Chen, C.T. Ting, S.J. Lin Which arterial and cardiac parameters best predict left ventricular mass? Circulation 98 1998 422 428
26. C.H. Chen, C.T. Ting, A. Nussbacher Validation of carotid artery tonometry as a means of estimating augmentation index of ascending aortic pressure Hypertension 27 1996 168 175
27. R.N. Foley, P.S. Parfrey, J.D. Harnett Clinical and echocardiographic disease in patients starting end-stage renal disease therapy Kidney Int 47 1995 186 192
28. G.M. London, B. Pannier, A.P. Guerin Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis Follow-up of an interventional study J Am Soc Nephrol 12 2001 2759 2767
29. P. Weidmann, M.H. Maxwell, A.N. Lupu, A.J. Lewin, S.G. Massry Plasma renin activity and blood pressure in terminal renal failure N Engl J Med 285 1971 757 762
30. A.Y. Wang, P.K. Li, S.F. Lui, J.E. Sanderson Angiotensin converting enzyme inhibition for cardiac hypertrophy in patients with end-stage renal disease What is the evidence? Nephrology (Carlton) 9 2004 190 197
31. M. Ozkahya, E. Ok, M. Cirit Regression of left ventricular hypertrophy in haemodialysis patients by ultrafiltration and reduced salt intake without antihypertensive drugs Nephrol Dial Transplant 13 1998 1489 1493
32. G. Cannella, E. Paoletti, R. Delfino, G. Peloso, D. Rolla, S. Molinari Prolonged therapy with ACE inhibitors induces a regression of left ventricular hypertrophy of dialyzed uremic patients independently from hypotensive effects Am J Kidney Dis 30 1997 659 664
33. E.R. Debusmann, J.O. Pujadas, W. Lahn Influence of renal function on the pharmacokinetics of ramipril (HOE 498) Am J Cardiol 59 1987 70D 78D
34. J.P. Fillastre, J.C. Baguet, D. Dubois Kinetics, safety, and efficacy of ramipril after long-term administration in hemodialyzed patients J Cardiovasc Pharmacol 27 1996 269 274
35. G.M. London, S.J. Marchais, M.E. Safar Aortic and large artery compliance in end-stage renal failure Kidney Int 37 1990 137 142
36. J. Blacher, A.P. Guerin, B. Pannier, S.J. Marchais, G.M. London Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease Hypertension 38 2001 938 942
37. A.P. Guerin, J. Blacher, B. Pannier, S.J. Marchais, M.E. Safar, G.M. London Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure Circulation 103 2001 987 992
38. J. Mayet, A.V. Stanton, A.M. Sinclair The effects of antihypertensive therapy on carotid vascular structure in man Cardiovasc Res 30 1995 147 152
39. E.M. Lonn, S. Yusuf, V. Dzavik Effects of ramipril and vitamin E on atherosclerosis The study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE) Circulation 103 2001 919 925
40. A. Benetos, R. Asmar, D. Vasmant, P. Thiery, M. Safar Long lasting arterial effects of the ACE inhibitor ramipril J Hum Hypertens 5 1991 363 368
41. A.A. Ahimastos, A.K. Natoli, A. Lawler, P.A. Blombery, B.A. Kingwell Ramipril reduces large-artery stiffness in peripheral arterial disease and promotes elastogenic remodeling in cell culture Hypertension 45 2005 1194 1199
42. G. Cannella, E. Paoletti, R. Delfino, G. Peloso, S. Molinari, G.B. Traverso Regression of left ventricular hypertrophy in hypertensive dialyzed uremic patients on long-term antihypertensive therapy Kidney Int 44 1993 881 886